| ANAPTYSBIO INC. DL-,001 |
| USA |
| Gesundheit |
| US0327241065 / A2AJ8C |
| AN6 (Frankfurt) / ANAB (NASDAQ) |
| FRA:AN6, ETR:AN6, AN6:GR, NASDAQ:ANAB |
| - |
| https://www.anaptysbio.co.. |
|
AnaptysBio Inc. is a clinical-stage biotechnology ..
>Volltext.. |
| 889.05 Mio. EUR |
| 972.2 Mio. EUR |
| 147.03 Mio. EUR |
| -22.78 Mio. EUR |
| -73.42 Mio. EUR |
| -2.43 EUR |
| 300.57 Mio. EUR |
| 95.29 Mio. EUR |
| -125.86 Mio. EUR |
| 6.53 |
| 181.25% |
| 51.53% |
| - |
| - |
| - |
| - |
| ANAPTYSBIO |
| 21.11.25 |
|